BA3182
Phase 1Recruiting 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced Adenocarcinoma
Conditions
Advanced Adenocarcinoma
Trial Timeline
Jul 14, 2023 → Sep 15, 2028
NCT ID
NCT05808634About BA3182
BA3182 is a phase 1 stage product being developed by BioAtla for Advanced Adenocarcinoma. The current trial status is recruiting. This product is registered under clinical trial identifier NCT05808634. Target conditions include Advanced Adenocarcinoma.
What happened to similar drugs?
16 of 20 similar drugs in Advanced Adenocarcinoma were approved
Approved (16) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
6
Activity
15
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05808634 | Phase 1 | Recruiting |
Competing Products
20 competing products in Advanced Adenocarcinoma